Table 1. Characteristics of participants with diabetes, ATP III metabolic syndrome, or neither condition and individual components, in the MESA population.
| Neither condition (n = 4153) | MetS (n = 1769) | Diabetes without MetS (n = 180) | Diabetes with MetS (n = 676) | |
|---|---|---|---|---|
| TAC > 0 | 999 (24%) | 576 (33%) | 68 (38%) | 254 (38%) |
| TAC score (for those with TAC> 0)* | 207 (6) | 255 (6) | 252 (5) | 258 (5) |
| Age | 61 (10) | 63 (10) | 65 (10) | 65 (9) |
| Female | 2129 (51%) | 1042 (59%) | 48 (27%) | 359 (53%) |
| Ethnicity | ||||
| White | 1745 (42%) | 706 (40%) | 29 (16%) | 129 (19%) |
| Chinese American | 534 (13%) | 162 (9%) | 38 (21%) | 67 (10%) |
| African American | 1094 (26%) | 451 (26%) | 71 (39%) | 258 (38%) |
| Hispanic | 780 (19%) | 450 (25%) | 42 (23%) | 222 (33%) |
| Serum Glucose | 87 (9) | 96 (12) | 151 (62) | 151 (55) |
| BMI | 26.8 (4.9) | 30.9 (5.2) | 26.2 (3.7) | 31.7 (5.7) |
| Total cholesterol | 194 (34) | 197 (37) | 183 (34) | 190 (41) |
| HDL cholesterol | 55 (15) | 43 (10) | 53 (12) | 44 (12) |
| LDL cholesterol | 118 (30) | 118 (32) | 112 (30) | 112 (35) |
| Triglycerides | 104 (57) | 181 (91) | 97 (40) | 181 (153) |
| Lipid-lowering meds | 532 (13%) | 324 (18%) | 42 (23%) | 199 (29%) |
| Diastolic BP | 71 (10) | 74 (10) | 72 (11) | 72 (10) |
| Systolic BP | 122 (21) | 134 (21) | 125 (19) | 135 (22) |
| Anti-hypertensive meds | 1046 (25%) | 928 (53%) | 65 (36%) | 482 (71%) |
| Current smoker | 532 (13%) | 237 (14%) | 27 (15%) | 84 (13%) |
| Metabolic syndrome components† | ||||
| Abdominal obesity (large waist) | 1579 (38%) | 1502 (85%) | 25 (14%) | 561 (83%) |
| High blood pressure | 1756 (42%) | 1436 (81%) | 89 (49%) | 583 (86%) |
| Low high-density lipoprotein | 724 (17%) | 1296 (73%) | 18 (10%) | 418 (62%) |
| High triglycerides | 492 (12%) | 1146 (65%) | 11 (6%) | 360 (53%) |
| Impaired fasting glucose | 257 (6%) | 681 (39%) | 180 (100%) | 676 (100%) |
*
Geometric mean (sd).